Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2007

Primary Completion Date

January 24, 2020

Study Completion Date

January 24, 2020

Conditions

Breast Cancer

Interventions

BIOLOGICAL

QS21

BIOLOGICAL

sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine

OTHER

immunoenzyme technique

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Trial Locations (1)

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00470574 - Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter